Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
12,214
archived clinical trials in
Women's Studies

A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated:  10/26/2017
Volunteer Research Group/NOCCR
mi
from
Knoxville, TN
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated: 10/26/2017
Volunteer Research Group/NOCCR
mi
from
Knoxville, TN
Click here to add this to my saved trials
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated:  10/26/2017
DiscoveResearch, Inc.
mi
from
Bryan, TX
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated: 10/26/2017
DiscoveResearch, Inc.
mi
from
Bryan, TX
Click here to add this to my saved trials
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated:  10/26/2017
Advanced Research Associates
mi
from
Corpus Christi, TX
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated: 10/26/2017
Advanced Research Associates
mi
from
Corpus Christi, TX
Click here to add this to my saved trials
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated:  10/26/2017
Research Across America
mi
from
Dallas, TX
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated: 10/26/2017
Research Across America
mi
from
Dallas, TX
Click here to add this to my saved trials
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated:  10/26/2017
Brownstone Clinical Trials
mi
from
Fort Worth, TX
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated: 10/26/2017
Brownstone Clinical Trials
mi
from
Fort Worth, TX
Click here to add this to my saved trials
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated:  10/26/2017
Advances In Health, Inc.
mi
from
Houston, TX
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated: 10/26/2017
Advances In Health, Inc.
mi
from
Houston, TX
Click here to add this to my saved trials
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated:  10/26/2017
Womens Hospital of Texas
mi
from
Houston, TX
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated: 10/26/2017
Womens Hospital of Texas
mi
from
Houston, TX
Click here to add this to my saved trials
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated:  10/26/2017
TMC Life Research, Inc
mi
from
Houston, TX
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated: 10/26/2017
TMC Life Research, Inc
mi
from
Houston, TX
Click here to add this to my saved trials
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated:  10/26/2017
Protenium Clinical Research
mi
from
Hurst, TX
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated: 10/26/2017
Protenium Clinical Research
mi
from
Hurst, TX
Click here to add this to my saved trials
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated:  10/26/2017
MacArthur OB/GYN
mi
from
Irving, TX
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated: 10/26/2017
MacArthur OB/GYN
mi
from
Irving, TX
Click here to add this to my saved trials
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated:  10/26/2017
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated: 10/26/2017
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated:  10/26/2017
Stone Oak, LLC dba Discovery Clinical Trials
mi
from
San Antonio, TX
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated: 10/26/2017
Stone Oak, LLC dba Discovery Clinical Trials
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated:  10/26/2017
NECRSA
mi
from
Schertz, TX
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated: 10/26/2017
NECRSA
mi
from
Schertz, TX
Click here to add this to my saved trials
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated:  10/26/2017
PRO/ Salt Lake Women's Center
mi
from
Draper, UT
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated: 10/26/2017
PRO/ Salt Lake Women's Center
mi
from
Draper, UT
Click here to add this to my saved trials
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated:  10/26/2017
Jean Brown Research
mi
from
Salt Lake City, UT
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated: 10/26/2017
Jean Brown Research
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated:  10/26/2017
Wasatch Clinical Research
mi
from
Salt Lake City, UT
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated: 10/26/2017
Wasatch Clinical Research
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated:  10/26/2017
UVA/Midlife Health at North Ridge
mi
from
Charlottesville, VA
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated: 10/26/2017
UVA/Midlife Health at North Ridge
mi
from
Charlottesville, VA
Click here to add this to my saved trials
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated:  10/26/2017
Clinical Research Center at Eastern Virginia Medical School
mi
from
Norfolk, VA
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated: 10/26/2017
Clinical Research Center at Eastern Virginia Medical School
mi
from
Norfolk, VA
Click here to add this to my saved trials
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated:  10/26/2017
National Clinical Research - Richmond, Inc.
mi
from
Richmond, VA
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated: 10/26/2017
National Clinical Research - Richmond, Inc.
mi
from
Richmond, VA
Click here to add this to my saved trials
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated:  10/26/2017
Virginia Women's Center
mi
from
Richmond, VA
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated: 10/26/2017
Virginia Women's Center
mi
from
Richmond, VA
Click here to add this to my saved trials
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated:  10/26/2017
Tidewater Clinical Research Inc
mi
from
Virginia Beach, VA
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated: 10/26/2017
Tidewater Clinical Research Inc
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated:  10/26/2017
Seattle Women's Health, Research and Gynecology
mi
from
Seattle, WA
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated: 10/26/2017
Seattle Women's Health, Research and Gynecology
mi
from
Seattle, WA
Click here to add this to my saved trials
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated:  10/26/2017
North Spokane Women's Health
mi
from
Spokane, WA
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated: 10/26/2017
North Spokane Women's Health
mi
from
Spokane, WA
Click here to add this to my saved trials
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated:  10/26/2017
Radiant Research (St. Louis)
mi
from
Saint Louis, MO
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus
Status: Enrolling
Updated: 10/26/2017
Radiant Research (St. Louis)
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Treatment of Bacterial Vaginosis (BV) With Tinidazole
Tinidazole for the Treatment of Bacterial Vaginosis
Status: Enrolling
Updated:  10/26/2017
Jefferson County Department of Health - STD Clinic
mi
from
Birmingham, AL
Treatment of Bacterial Vaginosis (BV) With Tinidazole
Tinidazole for the Treatment of Bacterial Vaginosis
Status: Enrolling
Updated: 10/26/2017
Jefferson County Department of Health - STD Clinic
mi
from
Birmingham, AL
Click here to add this to my saved trials
Effect of Acetaminophen on Postpartum Blood Pressure Control in Preeclampsia With Severe Features
Effect of Acetaminophen on Postpartum Blood Pressure Control in Preeclampsia With Severe Features
Status: Enrolling
Updated:  10/29/2017
University of New Mexico Health Sciences Center
mi
from
Albuquerque, NM
Effect of Acetaminophen on Postpartum Blood Pressure Control in Preeclampsia With Severe Features
Effect of Acetaminophen on Postpartum Blood Pressure Control in Preeclampsia With Severe Features
Status: Enrolling
Updated: 10/29/2017
University of New Mexico Health Sciences Center
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Phase II Study of Spinal Radiosurgery
A Phase II Study of Spinal Radiosurgery
Status: Enrolling
Updated:  10/30/2017
University of Alabama at Birmingham/The Kirklin Clinic at Acton Road
mi
from
Birmingham, AL
A Phase II Study of Spinal Radiosurgery
A Phase II Study of Spinal Radiosurgery
Status: Enrolling
Updated: 10/30/2017
University of Alabama at Birmingham/The Kirklin Clinic at Acton Road
mi
from
Birmingham, AL
Click here to add this to my saved trials
Novii External Fetal Monitoring Device
Evaluation of the Novii External Fetal Monitoring Device: A Prospective, Randomized Comparison
Status: Enrolling
Updated:  10/30/2017
Intermountain Medical Center
mi
from
Murray, UT
Novii External Fetal Monitoring Device
Evaluation of the Novii External Fetal Monitoring Device: A Prospective, Randomized Comparison
Status: Enrolling
Updated: 10/30/2017
Intermountain Medical Center
mi
from
Murray, UT
Click here to add this to my saved trials
Novii External Fetal Monitoring Device
Evaluation of the Novii External Fetal Monitoring Device: A Prospective, Randomized Comparison
Status: Enrolling
Updated:  10/30/2017
McKay-Dee Hospital
mi
from
Ogden, UT
Novii External Fetal Monitoring Device
Evaluation of the Novii External Fetal Monitoring Device: A Prospective, Randomized Comparison
Status: Enrolling
Updated: 10/30/2017
McKay-Dee Hospital
mi
from
Ogden, UT
Click here to add this to my saved trials
Novii External Fetal Monitoring Device
Evaluation of the Novii External Fetal Monitoring Device: A Prospective, Randomized Comparison
Status: Enrolling
Updated:  10/30/2017
Utah Valley Hospital
mi
from
Provo, UT
Novii External Fetal Monitoring Device
Evaluation of the Novii External Fetal Monitoring Device: A Prospective, Randomized Comparison
Status: Enrolling
Updated: 10/30/2017
Utah Valley Hospital
mi
from
Provo, UT
Click here to add this to my saved trials
Novii External Fetal Monitoring Device
Evaluation of the Novii External Fetal Monitoring Device: A Prospective, Randomized Comparison
Status: Enrolling
Updated:  10/30/2017
LDS Hospital
mi
from
Salt Lake City, UT
Novii External Fetal Monitoring Device
Evaluation of the Novii External Fetal Monitoring Device: A Prospective, Randomized Comparison
Status: Enrolling
Updated: 10/30/2017
LDS Hospital
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated:  10/31/2017
Physicians Research Group
mi
from
Tempe, AZ
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated: 10/31/2017
Physicians Research Group
mi
from
Tempe, AZ
Click here to add this to my saved trials
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated:  10/31/2017
HRC Fertility
mi
from
Encino, CA
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated: 10/31/2017
HRC Fertility
mi
from
Encino, CA
Click here to add this to my saved trials
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated:  10/31/2017
Reproductive Associates of Delaware
mi
from
Newark, DE
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated: 10/31/2017
Reproductive Associates of Delaware
mi
from
Newark, DE
Click here to add this to my saved trials
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated:  10/31/2017
FL Fertility Institution
mi
from
Tampa, FL
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated: 10/31/2017
FL Fertility Institution
mi
from
Tampa, FL
Click here to add this to my saved trials
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated:  10/31/2017
Georgia Reproductive Specialists
mi
from
Atlanta, GA
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated: 10/31/2017
Georgia Reproductive Specialists
mi
from
Atlanta, GA
Click here to add this to my saved trials
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated:  10/31/2017
Fertility Centers of Illinois
mi
from
Chicago, IL
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated: 10/31/2017
Fertility Centers of Illinois
mi
from
Chicago, IL
Click here to add this to my saved trials
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated:  10/31/2017
Shady Grove Fertility RSC
mi
from
Rockville, MD
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated: 10/31/2017
Shady Grove Fertility RSC
mi
from
Rockville, MD
Click here to add this to my saved trials
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated:  10/31/2017
The Nevada Center for Reproductive Medicine
mi
from
Reno, NV
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated: 10/31/2017
The Nevada Center for Reproductive Medicine
mi
from
Reno, NV
Click here to add this to my saved trials
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated:  10/31/2017
Cooper Institute of Reproductive Hormonal Disorders, P.C.
mi
from
Marlton, NJ
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated: 10/31/2017
Cooper Institute of Reproductive Hormonal Disorders, P.C.
mi
from
Marlton, NJ
Click here to add this to my saved trials
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated:  10/31/2017
Institute for Reproductive Health
mi
from
Cincinnati, OH
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated: 10/31/2017
Institute for Reproductive Health
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated:  10/31/2017
Abington Reproductive Medicine, PC
mi
from
Abington, PA
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated: 10/31/2017
Abington Reproductive Medicine, PC
mi
from
Abington, PA
Click here to add this to my saved trials
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated:  10/31/2017
Main Line Fertility Center
mi
from
Bryn Mawr, PA
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated: 10/31/2017
Main Line Fertility Center
mi
from
Bryn Mawr, PA
Click here to add this to my saved trials
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated:  10/31/2017
Shady Grove Fertility RSC, Chesterbrook, PA
mi
from
Chesterbrook, PA
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated: 10/31/2017
Shady Grove Fertility RSC, Chesterbrook, PA
mi
from
Chesterbrook, PA
Click here to add this to my saved trials
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated:  10/31/2017
Univ Of Penn
mi
from
Philadelphia, PA
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated: 10/31/2017
Univ Of Penn
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated:  10/31/2017
Fertility Associates of Memphis
mi
from
Memphis, TN
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated: 10/31/2017
Fertility Associates of Memphis
mi
from
Memphis, TN
Click here to add this to my saved trials
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated:  10/31/2017
Texas Fertility Center
mi
from
Austin, TX
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated: 10/31/2017
Texas Fertility Center
mi
from
Austin, TX
Click here to add this to my saved trials
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated:  10/31/2017
Center for Assisted Reproduction
mi
from
Bedford, TX
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated: 10/31/2017
Center for Assisted Reproduction
mi
from
Bedford, TX
Click here to add this to my saved trials
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated:  10/31/2017
Fertility Specialists of Houston
mi
from
Houston, TX
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated: 10/31/2017
Fertility Specialists of Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated:  10/31/2017
Houston Fertility Institute
mi
from
Houston, TX
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated: 10/31/2017
Houston Fertility Institute
mi
from
Houston, TX
Click here to add this to my saved trials